ATG-101

· Antengene (Hangzhou) Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATG-101, covering 2025-06-09 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas [Phase 1]

See pricing